1-Aryl-3-Aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency Thereof

Patent No. EP2276744 (titled "1-Aryl-3-Aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency Thereof") was filed by Esteve Pharmaceuticals on Apr 24, 2009. The application was issued on Oct 1, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALLAFENT, ALISONJul 1, 2015FRKELLY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2276744

ESTEVE PHARMACEUTICALS
Application Number
EP09735235A
Filing Date
Apr 24, 2009
Status
Revoked
Oct 25, 2019
Publication Date
Oct 1, 2014